Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression

Journal of Nuclear Medicine

Volumn 43, Issue 8, 2002, Pages 1072-1083

  Tjuvajev, Juri Gelovani ^a   Doubrovin, Mikhail ^a   Akhurst, Timothy ^a   Cai, Shangde ^a   Balatoni, Julius ^a   Alauddin, Mian M ^a   Finn, Ronald ^a   Bornmann, William ^a   Thaler, Howard ^a   Conti, Peter S ^a   Blasberg, Ronald G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

2 fluoro 2 deoxy 1 D arabinofuranosyl 5 iodouracil; 9 3 fluoro 1 hydroxy 2 propoxymethyl guanine; 9 4 fluoro 3 (hydroxymethyl)butyl guanine; 124 I; 18F; HSV1 tk; PET; Reporter gene

Indexed keywords

9 (3 FLUORO 1 HYDROXY 2 PROPOXYMETHYL)GUANINE F 18; 9 [4 FLUORO 3 (HYDROXYMETHYL)BUTYL]GUANINE F 18; FIALURIDINE I 124; FIALURIDINE I 131; GUANINE DERIVATIVE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLIOMA CELL; HERPES SIMPLEX VIRUS 1; IMAGE ANALYSIS; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE;

ANIMALS; ARABINOFURANOSYLURACIL; CARBON RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION; HERPESVIRUS 1, HUMAN; IODINE RADIOISOTOPES; NUCLEOSIDES; RADIOPHARMACEUTICALS; RATS; RATS, NUDE; THYMIDINE KINASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036324348     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Imaging the expression of transfected genes in vivo
2. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy
3. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography
4. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase
5. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo
6. Imaging transcriptional regulation of p53 dependent genes in vivo with positron emission tomography
7. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo
8. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters
9. Quantification of target gene expression by imaging reporter gene expression in living animals
10. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase
11. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir
12. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
13. 18F]fluoroguanine derivatives: In vivo probes for imaging gene expression with positron emission tomography
14. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography
15. 18F]fluoropenciclovir: An improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET
16. 18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PET
17. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors
18. 18F]FHBG): A new potential imaging agent for viral infection and gene therapy using PET
19. 18F]FHBG: A reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression
20. Low energy cyclotron production and chemical separation of "no carrier added" iodine-124 from a reusable, enriched tellurium-124 dioxide/aluminum oxide solid solution target
21. 211At] astato-2′deoxyuridine, an α-particle-emitting eudoradiotherapeutic agent undergoing DNA incorporation
22. The in vitro evaluation of nucleoside analogues as probes for use in the noninvasive diagnosis of herpes simplex encephalitis
23. Radiolabelled pyrimidine nucleosides to monitor the expression of HSV-1 thymidine kinase in gene therapy
24. 124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression
25. 18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections
26. 14C] FMAU) in rat prostate tumor cells
27. 125I]iodovinyl)-2′-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene: evaluation as probes for monitoring gene therapy
28. Reporter gene imaging: Effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase
29. Deglycosylation of antiherpes viral 5-substituted arabinosyluracil derivatives by rat liver extract and enterobacteria cells
30. 14C]-5-iodo-(2′-fluoro-2′-deoxy-1-β -D-arabino-furanosyl)-cytosine in immuno-suppressed patients with herpesvirus infections
31. Ganciclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
32. 18F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET
33. The ENT family of eukaryote nucleoside and nucleobase transporters: Recent advances in the investigation of structure/function relationships and the identification of novel isoforms
34. +-dependent nucleoside transporter (CNT) family: Identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)
35. Nucleoside transporters of mammalian cells
36. Complex regulation of nucleoside transporter expression in epithelial and immune system cells
37. Structural modifications at the 2′- and 3′-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter
38. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy
39. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing
40. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates